Suggestions
Michelle Weiner
Physician / Medical Cannabis and CBD Expert & Educator
Dr. Michelle Weiner is a highly qualified medical professional with a diverse educational background. She studied DO, MPH, Medicine/ Public Health at Nova Southeasterna University, B.S., Nutritional Sciences/ Health Science Education at University of Florida, and Pain Management/ Physical Medicine and Rehabilitation at University of Miami. Dr. Weiner's expertise spans across various fields of medicine, public health, and nutrition.
Highlights
The power of group therapy to reduce cost and burnout burden (and increase accessibility): a new study reveals group therapy significantly reduces costs and increases patient access to psychedelic-assisted treatments for PTSD and MDD - and could save up to $12.3 BILLION in the next decade!
TLDR: 👉Group therapy for psychedelic-assisted treatments offers substantial savings: 50.9% for MDMA-PTSD and 34.7% for psilocybin-MDD.
👉 Treating all eligible PTSD and MDD patients in the U.S. within 10 years using group therapy could save up to $12.3 billion and reduce the need for thousands of full-time clinicians.
By increasing the number of patients treated per clinician, group psychedelic therapy could significantly: 🧭 Improve access to these promising new treatments 💰 Enhance cost-effectiveness and affordability for insurers ⏳ Accelerate provision to underserved populations facing clinician shortages
https://lnkd.in/gmQszyNj
In an age where 50 million people grapple with chronic pain amidst an opiate epidemic, and 300 million suffer from depression despite the prevalence of antidepressants, it's clear we need a shift.
I believe that unresolved trauma and unmitigated stress lie at the heart of these crises. By identifying and treating trauma, and reducing stress, we can significantly decrease the burden of chronic pain and depression.
Join me tomorrow (Saturday 2/24) at Biohacker Expo for my keynote on “Neuroplasticity, Psychedelics, and Integrative Pain Management for Whole Health,” where we'll explore the biopsychosocial model's role in increasing resilience, reducing disability, and enhancing quality of life.
Use code NOPAIN30 for 30% off your ticket (I speak at 1:30pm)
https://lnkd.in/eTzqM6Pk
